RiverPark Advisors’s Envoy Medical COCH Stock Holding History

RiverPark Advisors’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-98,738	Closed	-$997K	–	64
2022 Q4	$997K	Hold	98,738	–	–	0.48%	69
2022 Q3	$971K	Hold	98,738	–	–	0.32%	91
2022 Q2	$968K	Sell	98,738 -23,739	-19%	-$232K	0.31%	79
2022 Q1	$1.2M	Hold	122,477	–	–	0.22%	82
2021 Q4	$1.19M	Buy	122,477 +98,738	+416%	+$963K	0.14%	94
2021 Q3	$230K	Buy	+23,739	New	+$230K	0.03%	134

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RiverPark Advisors's COCH Position: Q1 2023 in Review

RiverPark Advisors sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 98,738 shares — an estimated $997K sold.

RiverPark Advisors first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $1.2M in Q1 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

RiverPark Advisors reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
RiverPark Advisors sold 98,738 Envoy Medical shares in Q1 2023, an estimated $997K.
RiverPark Advisors first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
RiverPark Advisors's Envoy Medical position peaked at $1.2M in Q1 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on RiverPark Advisors's 13F filing for Q1 2023, filed 3 May 2023.